Ma Theresa De Leon, RN, MD
***********@*****.*** 1337 Crane Crest Way Orlando Florida 32825 407-***-****
OBJECTIVE
To enhance medical research thru my experience with medical oncology clinical trials as a clinical research coordinator/preceptor for phase 2 to phase 4 clinical trials for 5 years and as a patient enrollment manager in phase 1 healthy and disease neurological trials for 2 years
WORK EXPERIENCE
Patient Enrollment Manager
PPD, now part of Thermo Fisher, Orlando, Florida
21Aug2021- Present
Managing phase 1 neurology healthy and disease clinical trials thru collaborating with CRU leadership and sponsor regarding patient enrollment by patient consenting, patient eligibility, and patient communication regarding patient status participation
Communicate with primary sponsor contact regarding patient status, patient enrollment, specific issues and study deliverables
Review and provide input on study enrollment and patient consenting with sponsor and CRU leadership thru managing and updating trial logs, patient consent and patient eligibility and patient status
Collaborates with CRU leadership regarding CRU patient status, enrollment and eligibility following study protocol with sponsor guidance
Mange risk assessment with patient enrollment status and eligibility by collaborating with Medical Director, Medical investigator and Director
Responsible for managing patient enrollment and patient status
Collaborating with CRU leadership regarding SOP implementation regarding CRU rules, regulations and management
Managing and collaborating with CRU leadership regarding SIV and sponsor access thru ERT and IRT in regards to patient enrollment and consenting
Responsible for managing proper consenting process and patient screening onsite with team
Collaborating and managing with sponsor and company CRA thru ePIP, ERT and IRT.
Collaborating with CRU leadership team, clinical research managers, medical director and investigators regarding patient enrollment status by managing team regarding laboratory results, patient communication, clinical trial logs and check in process
Managing with team regarding patient consenting process and screening patients in phase 1 neurology healthy and disease clinical trials
Managing with team and CRU leadership team regarding patient screening process using patient EMR and enrollment thru ERT, IRT and laboratory companies.
Assist in the development and maintenance of new processes and procedure to ensure efficient clinical research operations
Collaboration with clinical research managers and CRU leadership regarding patient enrollment and follow up status
Attending/managing SIV clinical trials
Responsible for managing team regarding HIPPAA rules and regulation regarding patient consenting, screening and enrollment
Lead Clinical research coordinator/ Preceptor- Gastrointestinal Cancer Disease Research
Co-Lead in Clinical research coordinator/Preceptor - Head, Neck, Thoracic and Lung Cancer Disease Research
Orlando Health Cancer Institute, Orlando, Florida
16Jul2018 – 13Aug2021
Responsible for managing sponsored and Investigator Initiated Trials in accordance with FDA and ICH/GCP regulations and guidelines
Responsible for confirmation of eligibility and enrollment of patients upon referral
Responsible for screening subject using patient EMR and enrolling subjects based on I&E criteria per research study protocol
Responsible for the overall ongoing progress of clinical research trials from pre-screens through study completion
Assist in the development and maintenance of new processes and procedure to ensure efficient clinical research operations
Coordinate studies for Gastrointestinal and Head & Neck, Thoracic clinical trial
Coordinate Gastrointestinal and Head & Neck, Thoracic Cancer clinical trials
Coordinate cancer registries
Coordinate Device trials
Responsible for clinical trial data collection upon subject enrollment, active surgical procedures, and study subject follow-up visits
Responsible for checking subject EMR during unscheduled visits and AE updates
Responsible for reviewing all elements of the current institutional IRB approved informed consent (IC) document, according to current FDA, NCI, and state, federal and institutional regulations with study candidates and/or legal representative
Assist new onboarded research coordinators, research fellows and research v volunteers with protocol and research training
Provides administrative support to the department by providing research meeting coordination, taking meeting minutes, and coordinating necessary travel arrangements with a high level of accuracy and good judgment.
Work closely with the PI, participates in an integral way in the informed consent process by communicating clearly and openly with potential study patients about protocols open to enrollment
Coordinate and attend sponsor prequalification visits, monitor visits, study termination visits.
Making outbound calls to assess and follow up patient status
Respond to data clarification requests in a timely manner
Responsible for database construction with input from department director or immediate supervisor
Provides administrative support to the department by assisting with policy and procedure development and annual updates, upkeep of regulatory binders, and filing.
Provides administrative support to the department by conducting data entry into established databases with a high level of accuracy.
Identify gaps and or barriers in treatment plans
Demonstrates through human subject advocacy and informed consent as an ongoing process, that the rights, safety, and well-being of trial subjects are the most important considerations and should prevail over the interests of science and society
Responsible for special projects as assigned by department director and immediate supervisor
Interact with medical directors on challenging cases
Responsible for the immediate oversight of the study conduct during the pre-study, active and follow up phase, for all assigned studies.
Responsible for accurate and timely submission of data forms for assigned studies
Responsible for communication across a wide variety of internal hospital departments and the principal investigators (PI) of assigned studies.
Promotes PI oversight by advising the PI, sub-investigator, and department director or immediate supervisor of deviations in conduct, subject or study status, issues relevant to the integrity of the trial and/or the safety of research subjects
Maintain study database that records details of clinical trial shipments, and in collaboration with the CRA ensure that there are adequate supplies of clinical trial material to meet project needs
Schedule patients for study visits using Microsoft Outlook Calendar
Utilize CERNER System to update patients’ medical records and for patient registration
Assist in the development and implementation of recruitment strategies to increase patient randomization into the trial
Maintain a study database that records details of clinical trial shipments, and in collaboration with the CRA ensure that there are adequate supplies of clinical trial material to meet project needs.
Enters and updates patients’ Personal Health information (PHI) into database for recruiting
Assists with the analysis of research data using macros that enable machine to database communications
Use of IRB/NIH sites to obtain new research study protocols and inform consents (ICF)
Screen all patients based on study protocol I&E criteria
Data Management for responsible clinical trials
Coordinate with Research subject recruiting via phone or email
Coordinate with Patient Information Filing and coordination based on HIPAA regulations
Lead Clinical Research Coordinator/Preceptor- Gastrointestinal Cancer Disease Research
Lead Clinical Research Coordinator/Preceptor - Brain Cancer Disease Research
Co- Lead Clinical Research Coordinator- Genito-urinary/Renal Cancer Disease Research
Florida Hospital Cancer Institute, Orlando, Florida
04Aug2015-06Jul2018
Schedule patients for study visits using Microsoft Outlook Calendar
Utilize CERNER System to update patients’ medical records and for patient registration
Assist in the development and implementation of recruitment strategies to increase patient randomization into the trial
Maintain study database that records details of clinical trial shipments, and in collaboration with the CRA ensure that there are adequate supplies of clinical trial material to meet project needs.
Enters and updates patients’ Personal Health information (PHI) into database for recruiting
Assists with the analysis of research data using macros that enable machine to database communications
Use of IRB/NIH sites to obtain new research study protocols and inform consents (ICF)
Screen all patients based on study protocol I&E criteria
Data Management for responsible clinical trials
Proper documentation of patient visits and adverse events in regards to clinical drugs
Educate patients on cancer disease process and clinical trial drugs
Coordinate with Research subject recruiting via phone or email
Coordinate with Patient Information Filing and coordination based on HIPAA regulations
Responsible for managing sponsored and Investigator Initiated Trials in accordance with FDA and ICH/GCP regulations and guidelines
Responsible for confirmation of eligibility and enrollment of patients upon referral
Follow up and making calls for patient needs and updates and coordinating to all members of healthcare team so the patient can have resources and necessary services
Utilizing management skills to provide appropriate care and request appropriate health care services to patients, procedures and cancer treatment in relation to clinical trials
Responsible for screening subject using patient EMR and enrolling subjects based on I&E criteria per research study protocol
Responsible for the overall ongoing progress of clinical research trials from pre-screens through study completion
Responsible for enrolling subjects and coordinate research trials for hernia patients scheduled for surgery
Assist in the development and maintenance of new processes and procedure to ensure efficient clinical research operations
Coordinate studies for Gastrointestinal and Head & Neck, Thoracic clinical trial
Coordinate Gastrointestinal and Head & Neck, Thoracic Cancer clinical trials
Coordinate cancer registries
Coordinate Device trials
Responsible for clinical trial data collection upon subject enrollment, active surgical procedures, and study subject follow-up visits
Responsible for checking subject EMR during unscheduled visits and AE updates
Responsible for reviewing all elements of the current institutional IRB approved informed consent (IC) document, according to current FDA, NCI, and state, federal and institutional regulations with study candidates and/or legal representative
Assist new onboarded research coordinators, research fellows and research v volunteers with protocol and research training
Provides administrative support to the department by providing research meeting coordination, taking meeting minutes, and coordinating necessary travel arrangements with a high level of accuracy and good judgment.
Work closely with the PI, participates in an integral way in the informed consent process by communicating clearly and openly with potential study patients about protocols open to enrollment
Coordinate and attend sponsor prequalification visits, monitor visits, study termination visits.
Providing patient education on chemotherapy and oncology
Respond to data clarification requests in a timely manner
Coordinating care for patients and chemotherapy
Educate patients regarding healthy lifestyle and chemotherapy in regards with clinical trial
Responsible for database construction with input from department director or immediate supervisor
Provides administrative support to the department by assisting with policy and procedure development and annual updates, upkeep of regulatory binders, and filing.
Provides administrative support to the department by conducting data entry into established databases with a high level of accuracy.
Demonstrates through human subject advocacy and informed consent as an ongoing process, that the rights, safety, and well-being of trial subjects are the most important considerations and should prevail over the interests of science and society
Responsible for special projects as assigned by department director and immediate supervisor
Responsible for the immediate oversight of the study conduct during the pre-study, active and follow up phase, for all assigned studies.
Responsible for accurate and timely submission of data forms for assigned studies
Responsible for communication across a wide variety of internal hospital departments and the principal investigators (PI) of assigned studies.
Promotes PI oversight by advising the PI, sub-investigator, and department director or immediate supervisor of deviations in conduct, subject or study status, issues relevant to the integrity of the trial and/or the safety of research subjects
Maintain study database that records details of clinical trial shipments, and in collaboration with the CRA ensure that there are adequate supplies of clinical trial material to meet project needs
Inpatient Nurse/Preceptor, Medical Oncology Unit
Florida Hospital
Orlando, Florida
Aug/2008- Apr/2015
Inpatient Nurse, Medical Oncology Unit
MD Anderson Cancer Center, Orlando, Florida
Oct/2006- Apr/2008
LICENSES and CERTIFICATIONS
·State of Florida, Department of Health, Registered Nurse License RN# 9253607 Expires Jul2024
·BLS Certificate (CPR and AED)- Expires Aug2024
·ACLS Certification- Expires Jan2025
·Protecting Human Research Participants Online Training- Certification Number: 2870453
·Certificate of Completion- GECB (INQ1N)
·IRT certification- Medidata
EDUCATION
Bachelor of Science in Nursing, 28Mar1996
University of the East Ramon Magsaysay Memorial Medical Center
Quezon City, Philippines
Doctor of Medicine, 24Apr2002
Far Eastern University Nicanor Reyes Memorial Medical Center
Quezon City, Philippines
PROFESSIONAL DEVELOPMENT
·General Inpatient PCU Medical Oncology Training- Advent Health, Orlando, Florida
·Bone Marrow Transplant Inpatient Unit Training- Advent Health, Orlando, Florida
·National Cancer Institute Midyear Research Conference- Houston, Texas
PROFESSIONAL AFFILIATIONS
·Member, Society of Clinical Research Associates
CLINICAL TRIAL EXPERIENCE
CANCER CLINICAL TRIALS (PHASE 2- PHASE 4)
·Colon Cancer: 021502 Randomized Trial of Standard Chemotherapy Alone or Combined with XXX As Adjuvant Therapy For Patients With Stage III Colon Cancer And Deficient DNA Mismatch Repair- Orlando Health Cancer Institute
·Cholangiocarcinoma: A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral XXX Versus XXX with XXX in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations: the PROOF Trial- Orlando Health Cancer Institute
·Colorectal Cancer: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)- Orlando Health Cancer Institute
·Pancreatic Cancer: The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer- Orlando Health Cancer Institute
·Lung Cancer: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial XXX- Orlando Health Cancer Institute
·Colorectal cancer: Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer XXX - Orlando Health Cancer Institute
·Colorectal cancer: XXX, XXX, and XXX with or Without XXX in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery- Florida Hospital Cancer Institute
·Pancreatic Cancer: XXX and XXX vs XXX Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) (apact)- Florida Hospital Cancer Institute
·Pancreatic Cancer: Phase 2 XXX Plus XXX in Subjects with Locally Advanced Pancreatic Cancer (LAPC) (LAPACT)- Florida Hospital Cancer Institute
·Lung Cancer: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)- Orlando Health Cancer Institute
·Pancreatic Cancer: A Study of XXX Plus XXX with XXX in Adult Patients with Metastatic Pancreatic Adenocarcinoma XXX- Orlando Health Cancer Institute
·Hepatocellular Carcinoma: Study of XXX vs. Best Supportive Care in Participants with Previously Systemically Treated Advanced Hepatocellular Carcinoma XXX- Florida Hospital Cancer Institute
·Pancreatic Cancer: A Study of the Safety and Activity of XXX in Combination With the XXX and XXX in the Preoperative Treatment of Pancreatic Adenocarcinoma- Orlando Health Cancer Institute
·Rectal Cancer: PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery- Florida Hospital Cancer Institute
·Solid Tumors: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)- Orlando Health Cancer Institute
HEALTHY AND NEUROLOGY AND DISEASE CLINICAL TRIALS (PHASE 1)
A Phase 1 Study in Healthy Subjects to Evaluate the Relative Bioavailability of Risankizumab 150 mg/mL Formulation in Pre-filled Syringe Manufactured by Two Different Processes
A Phase 1, First-in-Human, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered AP-472 in Healthy Young Adult and Middle-Aged Subjects and Elderly Subject
A Phase 1, First in Human, Single and Multiple Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BMS-986419 and Food Effects on Relative Bioavailability in Healthy Participants
A Phase 1, First in Human, Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants
A Phase 1, First in Human, Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adult
A Phase 1, Two-part, Double-blind, Active-control, Randomized Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Repeat-Dose Cabotegravir (CAB 400 mg/mL formulation) Long-Acting Injection Following Subcutaneous or Intramuscular Administration in Healthy Adult Participants
An Open-Label, Randomized, Single-Dose, Multicenter, Parallel-Group Study to Compare the Pharmacokinetics of Subcutaneous Depemokimab When Delivered with a Safety Syringe Device or an Autoinjector in Healthy Adult Participants
A Phase I, multi-centre, open-label, single dose escalation study to evaluate the pharmacokinetics, safety and tolerability of long-acting cabotegravir co-administered with recombinant human hyaluronidase PH20 (rHuPH20) in healthy adult volunteers
Phase 1 Study of Daxdilimab to Evaluate Relative Bioavailability of New Formulation in Healthy Adult Participants and to Evaluate PK of Daxdilimab in Healthy Japanese Participants
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of PRX012 in Healthy Volunteers and Patients with Alzheimer’s Disease
An Ascending, Single, Oral Dose, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of DSP-2342 in Healthy Adult Subjects
Laboratory Evaluation Testing Protocol to Develop a Panel of Healthy Female Adults with the Human Platelet Antigen 1b/b Genotype
ADDITIONAL RELEVANT SKILLS
·12 Lead EKG Machine Curriculum Certification
·Inform CRC and PI Performing Data Entry
·Training for Shipping of Category A, Infectious Substance Affecting Humans Category B, Biological Substance- Orlando Health
·Annual Respirator N95 Training- Orlando Health
·Rave EDC training
·ECOG-ACRIN Supplemental eLearning
·EDC Inspection Readiness for Clinical Sites
·RAVE Query Management
·RAVE EDC Essentials for Clinical Research Coordinators
·Certificate of Achievement- ARGUS Overview Training
·Medidata IRT for Clinical Research Coordinators
·Clario ERT for EKG